Transmedics Group Inc (TMDX) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Transmedics Group Inc   (NASDAQ: TMDX)


Transmedics Group Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Transmedics Group Inc 's ROA in the third quarter of 2026?
Transmedics Group Inc achieved a return on average assets (ROA) of 10.66 % in its third quarter of 2026, this is above TMDX's average return on assets of -10.18%.
Transmedics Group Inc assets over the 12 months ending in its third quarter of 2026 are valued at $1,372 million

ROA fell compared to the second quarter of 2026, despite the net income growth of 3.37% from the second quarter of 2026.

However, within the Healthcare sector 90 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from 252 to 327.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 60.45 % 64.76 % 71.32 % 32.87 % 20.43 %
Y / Y Net Income Change -29.8 % -52.68 % -71.52 % 1436.87 % 476.83 %
Net Income (TTM) in million 146 154 172 190 92
Return On Assets (TTM) 10.66 % 12.49 % 15.85 % 20.34 % 10.55 %
TMDX's Total Ranking # 327 # 252 # 580 # 729 # 1010
Total Assets (TTM) in million 1,518 1,467 1,435 1,068 946
Seq. Total Assets Change 3.46 % 2.26 % 34.3 % 12.93 % 6.23 %
Seq. Net Income Change 3.37 % 125.8 % -93.06 % 333.34 % -30.33 %

TMDX's 5 Years Annual ROA >> Back to TMDX Management Effectiveness >> Compare TMDX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 24
Sector # 91
Overall # 568

Return On Assets Statistics
High Average Low
20.34 %
-10.18 %
-37.62 %
(Dec 31 2025)   (Jun 30 2022)





Financial Statements
Transmedics Group Inc 's Assets $ 1,518 million TMDX's Balance sheet
Transmedics Group Inc 's Income $ 17 million Quarterly TMDX's Income Statement
TMDX's Income by Division See TMDX's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 32.87 % 13.88 % 154.76 % 105.46 % -11.27 %
Total Assets in million 1,068 804 706 277 135
Y / Y Net Income Change 436.58 % - - - -
Net Income in million 190 35 -25 -36 -44
Annual Return On Assets 17.81 % 4.41 % -3.54 % -13.07 % -32.78 %

TMDX's 5 Years Annual ROA >> Back to TMDX Management Effectiveness >> Compare TMDX ROA to its Competitors



Comment on TMDX's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 17.81 % compared to prior year, due to annual net income growth of 436.58 % to $190.29 million, while value of Transmedics Group Inc 's overall assets grew just by 32.87 % to $1,068.37 million, compared to $1,068.37 a year before.


More Return On Assets Ratios
TMDX's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TMDX's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TMDX's Competitors
Subscribers only: Roa for Transmedics Group Inc 's Suppliers
Subscribers only: Return On Assets for TMDX's Customers

You may also want to know
TMDX's Roi TMDX's Inventory Turnover Ratio TMDX's Growth Rates TMDX's Dividend Comparisons
TMDX's Profitability Ratios TMDX's Asset Turnover Ratio TMDX's Dividend Growth
TMDX's Roe TMDX's Valuation Ratios TMDX's Financial Strength Ratios TMDX's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Zevra Therapeutics Inc   26.33 %
Caredx Inc   25.74 %
Medpace Holdings Inc   24.47 %
Acadia Pharmaceuticals Inc   21.60 %
Standard Biotools Inc   21.56 %
Eli Lilly And Company  21.24 %
Iradimed Corporation  20.89 %
Protalix Biotherapeutics inc   19.89 %
Electromed Inc   19.73 %
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Alpha Pro Tech Ltd   12.46 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %

Date modified: 2026-11-08T19:48:11+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.